版本:
中国

BRIEF-Aduro Biotech announces FDA clearance of investigational new drug application

June 1 Aduro Biotech Inc:

* Aduro Biotech announces FDA clearance of investigational new drug application to evaluate the combination of ADU-s100 with pdr001 for the treatment of solid tumors and lymphomas

* Aduro Biotech Inc - phase 1b study is expected to be initiated in second half of 2017

* Aduro Biotech says it will continue to evaluate potential of adu-s100 as a monotherapy in cutaneously accessible tumors as well as viscerally accessible tumors Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐